The beneficial effect of insulin, glucose, and dipyridamole on regional left ventricular function early after acute myocardial infarction

Int J Cardiol. 2005 Jul 10;102(2):255-8. doi: 10.1016/j.ijcard.2004.05.023.

Abstract

Background: High-dose glucose-insulin-potassium (GIK) solution has beneficial effects on reducing mortality in acute myocardial infarction. Dipyridamole (DIP) is a powerful antioxidant and increases adenosine concentration. Experimentally, GIK and DIP have additive protective effects in ischemia-reperfusion injury.

Aim: This work aims to assess the acute effects of DIP alone, GIK alone, and GIK+DIP on left ventricular function in patients evaluated early after an acute myocardial infarction.

Methods: Ten male patients (age 63+/-11 years) with uncomplicated acute myocardial infarction were evaluated within 3 days after admission. All had been treated with systemic thrombolysis and were on full therapy (including beta-blockers) at the time of testing. They underwent stress echocardiography [2D echo, with wall motion score index (WMSI) evaluated in a 16-segment model of the left ventricle, with each segment scored from 1=normal to 4=dyskinetic] during low-dose DIP alone (0.28 mg/kg in 4 min); GIK alone (4-h infusion of glucose 30%, 25 insulin units, and 40 mEq of KCl, at an infusion rate of 1.5 ml/kg/h); and GIK+DIP.

Results: Regional systolic function (baseline WMSI=1.69+/-0.2) improved after DIP (1.54+/-0.1), GIK (1.54+/-0.1), and, to a greater extent, after GIK+DIP (1.33+/-0.2; p<0.001 vs. baseline; p<0.05 vs. DIP; p<0.05 vs. GIK).

Conclusion: High-dose GIK has an acute beneficial effect on regional left ventricular function in patients with acute myocardial infarction. This beneficial effect is potentiated by low-dose DIP coadministration.

Publication types

  • Comparative Study

MeSH terms

  • Dipyridamole / administration & dosage
  • Dipyridamole / therapeutic use*
  • Drug Therapy, Combination
  • Echocardiography, Stress
  • Electrocardiography
  • Follow-Up Studies
  • Glucose / administration & dosage
  • Glucose / therapeutic use
  • Heart Ventricles / diagnostic imaging
  • Heart Ventricles / drug effects
  • Heart Ventricles / physiopathology*
  • Hospital Mortality / trends
  • Humans
  • Infusions, Intravenous
  • Insulin / administration & dosage
  • Insulin / therapeutic use
  • Italy / epidemiology
  • Male
  • Middle Aged
  • Myocardial Infarction / drug therapy*
  • Myocardial Infarction / mortality
  • Myocardial Infarction / physiopathology
  • Potassium / administration & dosage
  • Potassium / therapeutic use
  • Retrospective Studies
  • Stroke Volume / drug effects
  • Survival Rate / trends
  • Time Factors
  • Treatment Outcome
  • Vasodilator Agents / administration & dosage
  • Vasodilator Agents / therapeutic use*
  • Ventricular Function, Left / drug effects*

Substances

  • Insulin
  • Vasodilator Agents
  • glucose-insulin-potassium cardioplegic solution
  • Dipyridamole
  • Glucose
  • Potassium